Magdalena Kegel,  —

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

Articles by Magdalena Kegel

PAH Drugs of Limited Benefit in Sarcoidosis-linked Pulmonary Hypertension, Study Finds

Treatment with medications for pulmonary arterial hypertension (PAH) do not significantly help people with sarcoidosis-associated pulmonary hypertension (PH), researchers from France’s University of Paris-Sud reported. Their study, “Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension,” — published in the European Respiratory Journal — showed that while PAH-drugs improved some disease…

Study Supports Theory That Bacteria Causes Sarcoidosis, Researchers Say

Researchers found bacteria of the type Propionibacterium acnes in a large proportion of tissue samples from patients with cardiac sarcoidosis, suggesting that the bacteria may cause the formation of granulomas (abnormal collections of inflammatory cells), a typical feature of sarcoidosis. The work, published in the journal PLOS ONE, indicated that…

Study Details 3 Cancer Patients Who Developed Sarcoidosis After Dendritic Cell Vaccines

Sarcoidosis may appear in cancer patients who respond well to treatment with dendritic cell-based vaccines, according to a case series report from Germany. At the Friedrich-Alexander-University Erlangen-Nürnberg and the associated Erlangen University Hospital, researchers noted three patients with malignant melanoma who developed sarcoidosis after or during such treatment.

Abnormal Numbers of Certain T-Cells May Explain Melanoma-Sarcoidosis Link

Increased levels of a specific type of T-cell in some patients with melanoma might explain the connection between the cancer and sarcoidosis, researchers suggest in a study that explored melanoma patients treated with immunotherapy. The study, “Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and…